Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

26.00
Delayed Data
As of Apr 28
 +0.05 / +0.19%
Today’s Change
16.75
Today|||52-Week Range
39.99
+17.91%
Year-to-Date
No recent news for Lannett Company Inc.

Today’s Trading

Previous close25.95
Today’s open25.80
Day’s range25.45 - 26.25
Volume429,551
Average volume (3 months)937,264
Market cap$966.9M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-70.30%
Earnings growth (this year)+0.62%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+39.14%
P/E ratioNM
Price/Sales1.57
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.23-1.17%
ZIOPZIOPHARM Oncology In...-0.47-6.26%
FWPForward Pharma A/S+0.43+2.23%
ALDRAlder Biopharmaceuti...-1.30-6.09%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.86
Annual revenue (last year)$566.1M
Annual profit (last year)$44.8M
Net profit margin7.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts